Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines

Anaplastic thyroid cancer is one of the most aggressive human malignancies and the outcomes of conventional therapy have been far from satisfactory. Recently, epidermal growth factor receptor (EGFR)-targeted therapy has been introduced as an alternative therapeutic strategy for highly malignant canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobuhara, Y, Onoda, N, Yamashita, Y, Yamasaki, M, Ogisawa, K, Takashima, T, Ishikawa, T, Hirakawa, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361935/
https://www.ncbi.nlm.nih.gov/pubmed/15785737
http://dx.doi.org/10.1038/sj.bjc.6602461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361935/
https://www.ncbi.nlm.nih.gov/pubmed/15785737
http://dx.doi.org/10.1038/sj.bjc.6602461

Ejemplares similares